The calling card of Alzheimer’s disease is a buildup of misfolded amyloid protein in the brain, but many medicines struggle to penetrate the barrier protecting the mind from outside interference. A new study suggests that crossing the blood-brain barrier might not be necessary at all to clear amyloid plaques—and that a one-time gene therapy could one day prove an effective treatment for the devastating neurodegenerative disease.